Get the Stockscreener App
5.14
2.39%
0.12
After Hours:
5.15
0.01
+0.19%
Orchestra Biomed Holdings Inc stock is traded at $5.14, with a volume of 54,851.
It is up +2.39% in the last 24 hours and down -23.28% over the past month.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
See More
Previous Close:
$5.02
Open:
$4.97
24h Volume:
54,851
Relative Volume:
0.45
Market Cap:
$194.42M
Revenue:
$2.76M
Net Income/Loss:
$-49.12M
P/E Ratio:
-4.3581
EPS:
-1.1794
Net Cash Flow:
$-46.21M
1W Performance:
+6.86%
1M Performance:
-23.28%
6M Performance:
-2.47%
1Y Performance:
-41.06%
1-Day Range:
$4.91
$5.45
1-Week Range:
$4.50
$5.45
52-Week Range:
$4.22
$11.69
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Name
Orchestra Biomed Holdings Inc
Sector
Industry
Phone
646-343-9298
Address
150 UNION SQUARE DRIVE, NEW HOPE
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-24-23 | Initiated | Piper Sandler | Overweight |
| Feb-07-23 | Initiated | Chardan Capital Markets | Buy |
Orchestra Biomed Holdings Inc Stock (OBIO) Latest News
Rhumbline Advisers Buys 17,405 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider David P. Hochman Purchases 2,500 Shares - MarketBeat
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider David P. Hochman Purchases 2,500 Shares - Defense World
Orchestra BioMed executive acquires shares worth over $47k By Investing.com - Investing.com Australia
Orchestra BioMed executive acquires shares worth over $47k - Investing.com India
Orchestra BioMed executive acquires shares worth over $47k - Investing.com
Orchestra BioMed executive acquires shares worth over $47k By Investing.com - Investing.com UK
Market Update: Ocular Therapeutix Inc (OCUL) Sees Negative Movement, Closing at 8.46 - The Dwinnex
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Bought by Bank of New York Mellon Corp - Defense World
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Shares Sold by Logos Global Management LP - MarketBeat
Elevai Labs shares tumble on pricing of new stock offering - Sacramento Business Journal
Why Elevai Labs (ELAB) Stock Is Down 60% Today - Benzinga
Elevai Labs announces pricing of $8 million public offering - MSN
Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering - GlobeNewswire
Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering - StockTitan
L’Oreal partners with Evonik and Abolis to scale development of next-gen ingredients - GlobalCosmeticsNews
Video: A WONDERFUL WORLD Parades to Studio 54 - BroadwayWorld
The Cure 'Songs of a Lost World' billboard appears in NYC - Brooklyn Vegan
Exicure Shares More Than Double After Nasdaq Listing Extension - MarketWatch
Oxford Biomedica Emerges as OXB with Global Vision - TipRanks
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of European Wax Center, Inc.EWCZ - PR Newswire
Ocular Therapeutix Inc’s Market Journey: Closing Weak at 8.93, Down -0.78 - The Dwinnex
(OBIO) On The My Stocks Page - Stock Traders Daily
IPO NewsUP IPO Weekly Recap: 3 Biotechs Lead Active September IPO Market - Renaissance Capital
L'Oreal, Evonik join $38.6 million funding round for biotech start-up Abolis - Fashion Network
Interactive Bible Study Course Demonstrated to Over 200 Individuals at International Fair in Angola - JW News
L'Oreal, Evonik join $38.6 million funding round for biotech start-up Abolis - Marketscreener.com
Orchestra BioMed executive sells over $73k in company stock - Investing.com India
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Director Eric S. Fain Sells 2,000 Shares of Stock - MarketBeat
Orchestra BioMed director sells over $30k in company shares - Investing.com
Orchestra BioMed executive sells over $73k in company stock - Investing.com
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Sells $41,705.70 in Stock - Defense World
Have Orchestra BioMed Holdings Insiders Been Selling Stock? - Simply Wall St
Orchestra BioMed executive sells over $120k in company stock - Investing.com India
Insider Selling: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Sells 6,819 Shares of Stock - MarketBeat
Orchestra BioMed executive sells over $120k in company stock - Investing.com
Orchestra BioMed executive sells over $120k in company stock By Investing.com - Investing.com UK
Orchestra BioMed Initiates BackBeat Pivotal Study Of AVIM Therapy - MPO-mag
Orchestra BioMed (NASDAQ:OBIO) Receives New Coverage from Analysts at HC Wainwright - MarketBeat
Orchestra BioMed shares initiated with Buy by H.C. Wainwright - Investing.com
Orchestra BioMed shares initiated with Buy by H.C. Wainwright - Investing.com Australia
HC Wainwright Begins Coverage on Orchestra BioMed (NASDAQ:OBIO) - Defense World
Orchestra BioMed shares initiated with Buy by H.C. Wainwright - Investing.com India
Orchestra BioMed Holdings Reports Second Quarter 2024 Financial Results and Business Updates - MSN
David P. Hochman Acquires 2,500 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Stock - Defense World
Chardan Capital Comments on Orchestra BioMed Holdings, Inc.’s FY2024 Earnings (NASDAQ:OBIO) - Defense World
Research Analysts Set Expectations for Orchestra BioMed Holdings, Inc.'s FY2024 Earnings (NASDAQ:OBIO) - MarketBeat
Insider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Buys 2,500 Shares of Stock - MarketBeat
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Forecasted to Earn Q3 2024 Earnings of ($0.43) Per Share - Defense World
Q3 2024 Earnings Estimate for Orchestra BioMed Holdings, Inc. Issued By B. Riley (NASDAQ:OBIO) - MarketBeat
Orchestra BioMed (NASDAQ:OBIO) Announces Earnings Results, Misses Estimates By $0.04 EPS - MarketBeat
Orchestra Biomed Holdings Inc Stock (OBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):